Claude Preudhomme

Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study

Sylvie Castaigné, Cécile Pautas, Christine Terré et al. · The Lancet · 2012 · 975 citations

Hematological Malignancy, Oncology, Gemtuzumab Ozogamicin +8

A 17-gene stemness score for rapid determination of risk in acute leukaemia

Stanley Ng, Amanda Mitchell, Theodore A. Kennedy et al. · Nature · 2016 · 887 citations

Hematological Malignancy, Acute Leukaemia, 17-Gene Stemness Score +13

A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia

Pierre Fenaux, Claude Chastang, Sylvie Chevret et al. · Blood · 1999 · 743 citations

2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party

Michael Heuser, Sylvie Freeman, Gert J. Ossenkoppele et al. · Blood · 2021 · 666 citations · Full text

Mixed-phenotype Acute Leukemia, Pathology, Measurable Residual Disease +16

p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies

Eric Wattel, Claude Preudhomme, B Hecquet et al. · Blood · 1994 · 580 citations · Full text